| Systematic (IUPAC) name | |
|---|---|
| (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9- |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Controlled in the US via the Federal Analog Act |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS number | 65527-62-0 |
| ATC code | ? |
| PubChem | CID 44457783 |
| ChemSpider | 21106300 |
| ChEMBL | CHEMBL22694 |
| Synonyms | ETH-LAD, 6-ethyl-6-nor-Lysergic acid diethylamide |
| Chemical data | |
| Formula | C21H27N3O |
| Mol. mass | 337.47 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a hallucinogenic drug similar to LSD, and is slightly more potent than LSD itself,[1] with an active dose reported at between 40 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding.
ETH-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
|
|||||